Systematic Review Supports Preferred HIV Drugs in Youths

Data confirm the effectiveness and safety of dolutegravir and raltegravir for infants, children, and adolescents living with HIV, but researchers say that long-term monitoring is needed.

Related Keywords

Geneva ,Genè ,Switzerland ,Washington ,United States ,Claire Townsend ,Natella Rakhmanina ,Journal Of The International ,World Health Organization ,Children National Hospital ,Services Special Immunology ,Saharan Africa ,Special Immunology ,National Hospital ,Medscape Medical ,Antiretroviral Therapy ,Antiretroviral Therapy Art ,Art ,Atazanavir ,Darunavir ,Travirine ,Ipranavir ,Herapy Antiretroviral ,Pediatric Hiv Therapy ,Iv Therapy Pediatric ,Childhood Hiv Disease ,World Medicine ,Foreign Medicine ,International Medicine ,Global Medicine ,Ractice Of Medicine International ,Children ,Child ,Childhood ,Ediatrics ,Kids ,Hiv Infection ,Shiv ,Adolescent Medicine ,Ypati ,